Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary DiseaseA growing body of evidence suggests that in individuals with chronic lung disease their walk speed is related to their daily function and quality of life. It is possible to assess their usual (routine) and fast walking speeds by getting them to walk in a flat hallway. In individuals with chronic lung disease, we anticipate that their usual walk speed will be helpful in exercise prescription and use in multidimensional scoring systems. However, it is important to first determine the measurement properties of these two walk speeds.
Portable Oxygen Concentrator to Improve Quality of Life in Chronic Obstructive Pulmonary Disease...
COPDEvaluate subjects in an prospective observational study Subjects will be administered scientifically validated questionnaires Determine the affect of the Portable Oxygen Concentrator (POC) on improvements in: Exercise capability, dyspnea and quality of life as primary endpoints Utilize: Baseline Dyspnea Index (BDI) Transitional Dyspnea Index (TDI) Chronic Respiratory Disease Questionnaire (CRQ) Six minute walk test (6MWT) Epworth Sleepiness Scale (ESS) The secondary endpoints will be: Rate of exacerbations, sleep quality Health care utilization (emergency room encounters, hospital admissions)
Six Minute Walking Test and Breath-holding
Chronic Obstructive Pulmonary DiseaseTo compare the relationship between breath-hold time and the distance in a Six Minute Walking Test in chronic obstructive pulmonary disease population.
Observational Study of Obstructive Lung Disease (NOVELTY)
AsthmaCOPD1 moreThe NOVEL Observational longiTudinal studY (NOVELTY) is an observational study of obstructive lung disease and is a multi-country, multi-centre, prospective, longitudinal cohort study which will recruit patients with a diagnosis, or suspected diagnosis, of asthma and/or Chronic Obstructive Pulmonary Disease (COPD). Patients will undergo clinical assessments and receive standard medical care as determined by their treating physician. Patients enrolled in NOVELTY will be followed up yearly by their treating physician for a total duration of three years. In addition, patients will be followed up remotely every 3 months. The NOVELTY study will collect data currently lacking to allow for multinational data collection to fill regional/local gaps and improve comparability across regions.
The Economic Burden of Chronic Obstructive Pulmonary Disease(COPD) in South Korea
COPDChronic Obstructive Pulmonary DiseaseThe purpose of this study is to estimate a direct/indirect medical cost and to provide evidence establishing efficient strategies to reduce medical costs of COPD in Korea.
Balance Training for Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary DiseaseThe study will involve direct knowledge translation of a laboratory-based study of balance training for patients with COPD, first to the investigators PR program and then, after disseminating the results, this approach could be used to impact on clinical practice in any PR program.
Phenotypes of COPD in Central and Eastern Europe
Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to assess the representation of COPD patients in terms of categories and phenotypes of the disease in selected countries in Central and Eastern Europe (CEE). The results of The POPE study will allow for evaluation of the differences in clinical approaches and treatment practices. The following countries are represented in The POPE study: Czech Republic, Slovakia, Austria, Poland, Hungary, Russia, Croatia, Serbia, Slovenia, Estonia, Latvia and Bulgaria.
Validation of Medication Non-adherence Model (UK)
Diabetes MellitusChronic Obstructive Pulmonary Disease3 moreResearch has shown that nearly 50% of patients with chronic conditions around the globe do not adhere to their prescribed medicine, leading to enormous cost to the healthcare providers. Non-adherence can be due to various forms and have multiple causes. To address this need, Philips Research has developed Medication Non-adherence model. This tool will help in developing a systemic way of assessing medication non-adherence and providing decision support for targeted intervention to healthcare professionals. The aim of this study is to validate this model with 750 chronically ill patients in UK.
Role of Fibrocytes in the Bronchial Remodelling of Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary DiseaseAirway remodelling is an abnormal tissue repair following bronchial inflammation, which contributes to none reversible pathological features, such as bronchial and peri-bronchial fibrosis. It also influences the prognosis of Chronic Obstructive Pulmonary Disease (COPD) and its mechanisms remain largely unknown. The role of fibrocytes has been demonstrated in the pathophysiology of asthma, lung fibrosis or pulmonary hypertension. However, the recruitment of blood fibrocytes and their involvement in COPD airway remodelling remain unknown. The main objective of the study is to analyse the distribution and quantify the number of the peri-bronchial and blood circulating fibrocytes in patients with different stages of COPD compared to control subjects.
Handling Inhalers - Technique Error Comparison (HI-TEC)
Pulmonary DiseaseChronic Obstructive1 moreRandomised, cross sectional, observational study evaluating inhaler device critical errors (errors that could affect dose delivery to the lungs) for the Pulmojet inhaler compared to Diskus or Turbuhaler in asthma and COPD patients receiving regular maintenance inhaled steroid therapy.